Using a weighted histoscore for intensity that accounts for regional differences within a tumor, both PODXL and GAL3 showed no clear pattern or directionality of change in total labeling between primary prostate tumors and metastases (n = 6 shRNA scramble control mice with PTs and metastasis; Fig. 7, G and H). The gene discussed is PODXL; the disease is prostate neoplasm.